Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2020, Vol. 34 ›› Issue (6): 72-76.doi: 10.6040/j.issn.1673-3770.0.2019.618

Previous Articles     Next Articles

Expression and clinical significance of CPS1 in laryngeal squamous cell carcinoma

FAN Yiyan1,2, ZHANG Xiaolin1, LIU Xiuzhen3, YIN Jingjing1, YUAN Jin1, WANG Yanfei1, CHEN Jun1   

  1. 1. Otorhinolaryngology & Head and Neck Surgery, Binzhou Medical University Hospital, Binzhou 256603, Shandong, China;
    2. Department of Otolaryngology, Shengli Oilfield Central Hospital, Dongying 257000, Shandong, China;
    3. Clinical Medical Laboratory, Binzhou Medical University Hospital, Binzhou 256603, Shandong, China
  • Published:2021-01-11

PDF (PC)

189

Abstract: Objective To study the expression levels of carbamoyl phosphate synthase I(CPS1)in laryngeal squamous cell carcinoma and adjacent non-cancerous tissues and reveal its possible correlation with clinical parameters, and explore the clinical significance of CPS1 in the disease. Methods The real-time quantitative polymerase chain reaction(RT-qPCR)was used to measure the expression of CPS1 mRNA in laryngeal squamous cell carcinoma and adjacent tissues. Western blotting and immunohistochemistry were used to detect expression levels of the CPS1 protein and its distribution in laryngeal squamous cell carcinoma tissues. Results The results of RT-qPCR and western blot analysis showed that the mRNA and protein expression levels of CPS1 in laryngeal squamous cell carcinoma were significantly higher than that in adjacent tissues(P<0.01). Immunohistochemistry showed the same trend in CPS1 protein levels. The expression of CPS1 was closely related to the degree of tumor differentiation, clinical stage, and lymph node metastasis(P<0.05), but not to the patients' age, gender, smoking history, drinking history, and tumor site(P>0.05). Conclusion The expression of CPS1 in laryngeal squamous cell carcinoma is significantly higher than in the adjacent tissues, and is closely related to clinical progression. These results suggest that CPS1 may play a role in the occurrence and metastasis of laryngeal cancer, and is a diagnostic indicator for laryngeal cancer.

Key words: Carbamyl phosphate synthase 1, Laryngeal squamous cell carcinoma, Clinical progress

CLC Number: 

  • R739.65
[1] Zhu L, Qin G, Ye L, et al. Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma[J]. Oncol Lett, 2019, 17(6): 5699-5704. doi:10.3892/ol.2019.10226.
[2] 邹良玉,李连贺,岳文慧,等. MIF、GSK-3β在喉鳞状细胞癌中表达的临床意义及相关性研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 76-80. doi:10.6040/j.issn.1673-3770.0.2018.423. ZOU Liangyu, LI Lianhe, YUE Wenhui, et al. Clinical significance and correlation between MIF and GSK-3βexpression in laryngeal squamous cell carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 76-80. doi:10.6040/j.issn.1673-3770.0.2018.423.
[3] 许莉, 王志颐, 陈伟,等. MicroRNA-24对人喉鳞癌细胞生物学行为的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 30-37. doi:10.6040/j.issn.1673-3770.0.2018.021. XU Li, WANG Zhiyi, CHEN Wei, et al. Effect of MicroRNA-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 30-37. doi:10.6040/j.issn.1673-3770.0.2018.021.
[4] Markou K, Christoforidou A, Karasmanis I, et al. Laryngeal cancer: epidemiological data from Νorthern Greece and review of the literature[J]. Hippokratia, 2013, 17(4): 313-318.
[5] Yan ZY, Liu G, Liang M, et al. Ophiopogonin D inhibits cell proliferation and induces apoptosis of human laryngocarcinoma through downregulation of cyclin B1 and MMP-9 and upregulation of p38-MAPK signaling[J]. Oncol Lett, 2019, 17(2): 1877-1882. doi:10.3892/ol.2018.9788.
[6] Zhang B, Fu T, Zhang L. MicroRNA-153 suppresses human laryngeal squamous cell carcinoma migration and invasion by targeting the SNAI1 gene[J]. Oncol Lett, 2018, 16(4): 5075-5083. doi:10.3892/ol.2018.9302.
[7] Zhuang S, Liu F, Wu P. Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis[J]. J Cell Biochem, 2019, 120(8): 13392-13402. doi:10.1002/jcb.28614.
[8] Butler SL, Dong H, Cardona D, et al. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1[J]. Lab Invest, 2008, 88(1): 78-88. doi:10.1038/labinvest.3700699.
[9] Diez-Fernandez C, Martínez AI, Pekkala S, et al. Molecular characterization of carbamoyl-phosphate synthetase(CPS1)deficiency using human recombinant CPS1 as a key tool[J]. Hum Mutat, 2013, 34(8): 1149-1159. doi:10.1002/humu.22349.
[10] Yang C, Fu R, Zhuang ZH, et al. Studies on the biological functions of CPS1 in AFB1 induced hepatocarcinogenesis[J]. Gene, 2016, 591(1): 255-261. doi:10.1016/j.gene.2016.07.031.
[11] Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon[J]. Am J Clin Pathol, 2004, 121(6): 884-892. doi:10.1309/A09E-RYMF-R64N-ERDW.
[12] Thamboo TP, Wee A. Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis[J]. J Clin Pathol, 2004, 57(1): 48-53. doi:10.1136/jcp.57.1.48.
[13] Palaniappan A, Ramar K, Ramalingam S. Computational identification of novel stage-specific biomarkers in colorectal cancer progression[J]. PLoS One, 2016, 11(5): e0156665. doi:10.1371/journal.pone.0156665.
[14] Daniel P, Halada P, Jelínek M, et al. Differentially expressed mitochondrial proteins in human MCF7 breast cancer cells resistant to paclitaxel[J]. Int J Mol Sci, 2019, 20(12): E2986. doi:10.3390/ijms20122986.
[15] Çeliktas M, Tanaka I, Tripathi SC, et al. Role of CPS1 in cell growth, metabolism and prognosis in LKB1-inactivated lung adenocarcinoma[J]. J Natl Cancer Inst, 2017, 109(3): 1-9. doi:10.1093/jnci/djw231.
[16] Li J, Chen L, Zhang XF, et al. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and Pan-cytokeratin[J]. PLoS One, 2014, 9(4): e96185. doi:10.1371/journal.pone.0096185.
[17] Milinkovic V, Bankovic J, Rakic M, et al. Identification of novel genetic alterations in samples of malignant glioma patients[J]. PLoS One, 2013, 8(12): e82108. doi:10.1371/journal.pone.0082108.
[18] Kinoshita M, Miyata M. Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci[J]. Hepatology, 2002, 36(2): 433-438. doi:10.1053/jhep.2002.34851.
[19] Liu HY, Dong HJ, Robertson K, et al. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1(CPS1)in human hepatocellular carcinoma[J]. Am J Pathol, 2011, 178(2): 652-661. doi:10.1016/j.ajpath.2010.10.023.
[20] Lee YY, Li CF, Lin CY, et al. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy[J]. Tumour Biol, 2014, 35(11): 11097-11105. doi:10.1007/s13277-014-2425-8.
[21] Liu X, Zhang XT, Bi JB, et al. Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells[J]. J Cell Mol Med, 2019, 23(12): 8128-8138. doi:10.1111/jcmm.14683.
[22] Li L, Mao YX, Zhao LN, et al. p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis[J]. Nature, 2019, 567(7747): 253-256. doi:10.1038/s41586-019-0996-7.
[23] 刘义文, 廖春娇, 黄顺东. 肝癌组织中SIRT5的表达及其临床病理意义[J]. 中国医学创新, 2019, 16(4): 136-139. doi:10.3969/j.issn.1674-4985.2019.04.035. LIU Yiwen, LIAO Chunjiao, HUANG Shundong. The expressions and clinicopathological significance of SIRT5 in hepatocellular carcinoma[J]. Medical Innovation of China, 2019, 16(4): 136-139. doi:10.3969/j.issn.1674-4985.2019.04.035.
[24] 李佳峰, 孙宇哲, 李庆昌. Sirtuin 4和Sirtuin 5蛋白在代谢性疾病与肿瘤中的研究进展[J]. 现代肿瘤医学, 2018, 26(21): 3516-3519. doi:10.3969/j.issn.1672-4992.2018.21.043. LI Jiafeng, SUN Yuzhe, LI Qingchang. Progress in the research of Sirtuin 4/5 proteins in metabolic diseases and tumors: a review[J]. Journal of Modern Oncology, 2018, 26(21): 3516-3519. doi:10.3969/j.issn.1672-4992.2018.21.043.
[25] Cardona DM, Zhang XK, Liu C. Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma[J]. Am J Clin Pathol, 2009, 132(6): 877-882. doi:10.1309/ajcp74xgrfwtflju.
[1] LIU Yong, YUAN Cunli, CAO Hui, ZHENG Chengcai, CHAO Fang, XU Fenglei. CHD1L promotes proliferation, invasion and metastasis of laryngeal squamous cell carcinoma cells by EMT [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 32-39.
[2] CHEN Huijun, SONG Shenghua, DONG Weida, ZHOU Han. Prognostic role of preoperative fibrinogen levels in patients with laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(2): 110-114.
[3] WANG Kuirong, RAO Lihua, LI Zhuan, DUAN Bingzhi. Association between Helicobacter pylori and laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 38-42.
[4] ZHANG Mingde, ZHANG Zuping, YU Xuemin, WEI Yanhong, YUAN Ying. RASSF2A methylation in laryngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 64-67.
[5] ZHU Xiaocheng, QIAN Xiaoyun, GU Yajun, SHEN Xiaohui, SONG Panpan, LI Hui, GAO Xia. Expression and clinical value of MGMT and EGFR in laryngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 68-72.
[6] LIU Fang1, LAI Jian-xin1, LI Rui-yu1, LI Guan-zhen2. Th17/Treg cell ratio in the peripheral circμlation of human laryngeal squamous cell carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 4-7.
[7] XU Hai-yan1, PENG Jie-ren1, OU Yong-kang1, ZHANG Qiong-xia2, ZHANG Cun-liang1, TANG Zhi-ping1, GUAN Zhong1. Expression and clinicopathological significance of nuclear epidermal growth factor receptor, Aurora-A kinase in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(5): 16-21.
[8] WU Gui-qing1, TIAN Jun2, SUN Jing1, CHEN Qi1. 1. Expression and significance of Tiam1 and MTA1in human laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(1): 41-43.
[9] . Expression of the KAI1 gene in laryngeal carcinoma and metastasis lymph nodes [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(2): 11-13.
[10] XU Zhi-jian ,PENG Jie-ren,HUANG Xiao-ming,GUAN Zhong,ZHU Xiao-fen,LIAO Yan-ping . Expression of the Ras-GTPase-activiting protein SH 3 domain binding protein
in laryngeal squamous cell carcinoma and it clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(5): 401-404 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] LIN Bin,WANGHui-ge . Functional endoscopic sinus surgery, FESS[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(6): 481 -487 .
[2] GONG Lei,SUN Jie,XUE Zi-chao,LI Jing-hua,XUE Wei-guo . DNA analysis of the cell cycle in sino-nasal neoplasm[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 193 -195 .
[3] CHEN Wen-wen . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(5): 472 -472 .
[4] LUAN Jiangang,LIANG Chuanyu,WEN Yanjun,LI Jiong . Construction of RNAi expressing plasmid vector of pSIRENshuttle for EGFR gene silencing[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 4 -8 .
[5] MA Jing, ZHONG Cui-ping . Surgical method for nasopharyngeal fibroangioma encroaching on fossa pterygopalatina: with a report of 5 cases[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 30 -32 .
[6] LIU Qiang-he,LUO Xiang-lin,GENG Wan-ping,CHEN Chen,LEI Xun,LIU Fang-xian,DENG Ming . Age-related spiral ganglion neuron damages and hearing loss in senescence accelerated mice[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 215 -217 .
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 223 -226 .
[8] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 246 -247 .
[9] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 250 -252 .
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 260 -262 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd